[1] 刘晓伟,韩颖.基于Cov-AHP-模糊综合评价法的PPP项目风险评价研究[J].辽宁工业大学学报(自然科学版),2018,38(5):336-341. [2] 徐炜,王文娟,陈雪礼,等.联合德尔菲法与模糊综合评价法在临床输血病历质量管理中的应用评价[J].中国输血杂志,2018,31(7):717-721. [3] 中华人民共和国卫生部.医疗机构临床用血管理办法[S].2012. [4] 中华人民共和国卫生部.临床输血技术规范[S].2000. [5] 谢忠秋. Cov-AHP:层次分析法的一种改进[J].数量经济技术经济研究,2015,32(8):137-148. [6] 李鲁洁,董娜,熊峰,等.基于Cov-AHP与等级联系度的施工项目管理绩效评价研究[J].广西师范大学学报(自然科学版),2019,37(3):111-119. [7] KARIM F,ALI N,ADIL S N.Haemovigilance[J].J Pak Med Assoc,2012,62(12):1270. [8] WOOD E M,ANG A L,BISHT A,et al.International haemovigilance: what have we learned and what do we need to do next?[J].Transfus Med,2019,29(4): 221-230. [9] ANDREU G,MOREL P,FORESTIER F,et al.Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998[J].Transfusion,2002,42(10):1356-1364. [10] JUJI T,NISHIMURA M,TADOKORO K.Treatment of post transfusion graft-versus-host disease[J].Vox Sang,2000,78(Suppl 2):277-279. [11] WILLIAMSON L,COHEN H,LOVE E,et al.The Serious Hazards of Transfusion (SHOT) initiative: the UK approach to haemovigilance[J].Vox Sang,2000,78(Suppl 2):291-295. [12] WHITAKER B I,BELOV A,ANDERSON S A.Progress in US hemovigilance: can we still learn from others?[J].Transfusion,2019,59(2):433-436. [13] 梁文飚,孙俊.血液预警——提高输血安全的有效工具[J].江苏卫生事业管理,2013,24(6):257-260. [14] 贾桂丛,张采红,刘斯文,等.血液安全监测文献综述及启示[J].中国卫生质量管理,2016,23(5):84-87. [15] BENJAMIN R J,BRASCHLER T,WEINGAND T,et al.Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems[J].Transfusion,2017,57(12):2946-2957. |